Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 24, 2023

SELL
$119.0 - $147.98 $14,756 - $18,349
-124 Reduced 3.88%
3,071 $0
Q3 2022

Nov 10, 2022

SELL
$118.07 - $160.96 $48,054 - $65,510
-407 Reduced 11.3%
3,195 $385,000
Q2 2022

Aug 11, 2022

SELL
$134.91 - $172.49 $22,529 - $28,805
-167 Reduced 4.43%
3,602 $512,000
Q1 2022

Apr 20, 2022

SELL
$162.31 - $192.2 $32,462 - $38,440
-200 Reduced 5.04%
3,769 $658,000
Q4 2021

Feb 02, 2022

BUY
$166.66 - $201.06 $27,165 - $32,772
163 Added 4.28%
3,969 $798,000
Q3 2021

Oct 28, 2021

SELL
$151.98 - $190.5 $168,697 - $211,455
-1,110 Reduced 22.58%
3,806 $660,000
Q2 2021

Aug 13, 2021

SELL
$127.81 - $155.84 $84,865 - $103,477
-664 Reduced 11.9%
4,916 $759,000
Q1 2021

May 06, 2021

BUY
$120.35 - $160.53 $75,940 - $101,294
631 Added 12.75%
5,580 $716,000
Q4 2020

Feb 09, 2021

BUY
$122.05 - $147.91 $604,025 - $732,006
4,949 New
4,949 $710,000

Others Institutions Holding PKI

About PERKINELMER INC


  • Ticker PKI
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 126,224,000
  • Market Cap $15.3B
  • Description
  • PerkinElmer, Inc. provides products, services, and solutions to the diagnostics, life sciences, and applied services markets worldwide. It operates through two segments, Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment offers a suite of solutions, including reagents, informatics, and detectio...
More about PKI
Track This Portfolio

Track Sigma Planning Corp Portfolio

Follow Sigma Planning Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sigma Planning Corp, based on Form 13F filings with the SEC.

News

Stay updated on Sigma Planning Corp with notifications on news.